Published November 2018
| Version v1
Journal article
Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT)
- 1. Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto (Canada)
Description
We report mature outcomes for a cohort of patients with no prior radiation (de novo) to the spine treated with 24 Gy in 2 daily fractions for metastases, which represents the same stereotactic body radiation therapy (SBRT) regimen under evaluation in the current Symptom Control-24 phase 3 randomized trial (NCT02512965).
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2018.06.047Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2018.06.047;
- PII
- S0360301618310484;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 102
- Journal Issue
- 3
- Journal Page Range
- p. 499-507
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54107138
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BONE TISSUES; EVALUATION; METASTASES; PATIENTS; RADIOTHERAPY; SYMPTOMS
- Descriptors DEC
- ANIMAL TISSUES; BODY; CONNECTIVE TISSUE; MEDICINE; NUCLEAR MEDICINE; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2018 The Author(s). Published by Elsevier Inc.